Plant dipeptidyl peptidase-IV inhibitors as antidiabetic agents: a brief review.

Abstract:

:Diabetes mellitus is an increasing public health problem in the world. Type 2 diabetes is the most common type of diabetes whose complications contribute to its high death rate. It seriously impacts healthcare systems and patients' quality of life. Therefore, effective measures and new treatment strategies are needed to solve this increasingly serious global problem. In recent years, inhibition of dipeptidyl peptidase IV (DPP-IV) has emerged as a new treatment option for Type 2 diabetes. This article reviews various plant DPP-IV inhibitors that showed inhibition toward enzyme as a major target for the management of Type 2 diabetes. These studies can contribute to the future development of DPP-IV inhibitors as drugs.

journal_name

Future Med Chem

authors

Turdu G,Gao H,Jiang Y,Kabas M

doi

10.4155/fmc-2017-0235

subject

Has Abstract

pub_date

2018-05-01 00:00:00

pages

1229-1239

issue

10

eissn

1756-8919

issn

1756-8927

journal_volume

10

pub_type

杂志文章,评审
  • Antimicrobial, anti-TB, anticancer and anti-HIV evaluation of new s-triazine-based heterocycles.

    abstract:BACKGROUND:The acquirement of resistance by microorganisms to the antimicrobial arsenal is a threat to public health. A recent WHO report estimated that 1.3 million HIV-negative people and 0.38 million HIV-positive people died from TB in 2009. Various forms of cancer account for a high percentage of deaths in both wome...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc.12.57

    authors: Patel RV,Kumari P,Rajani DP,Pannecouque C,De Clercq E,Chikhalia KH

    更新日期:2012-06-01 00:00:00

  • Recent advances in research of natural and synthetic bioactive quinolines.

    abstract::Many natural products that consist of quinoline core are found to be bioactive and the versatility of quinoline and its derivatives have attracted great attention in the field of drug development. As a result, in recent years, many green and sustainable synthetic approaches for the synthesis of structurally diverse qu...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc.15.34

    authors: Chung PY,Bian ZX,Pun HY,Chan D,Chan AS,Chui CH,Tang JC,Lam KH

    更新日期:2015-01-01 00:00:00

  • Selective and potent small-molecule inhibitors of PI3Ks.

    abstract::Class I PI3Ks are composed of four catalytic subunit variants (p110α, p110β, p110δ and p110γ). The PI3K pathway is among the most frequently activated pathways in many diseases, and has emerged as an attractive target for drug development, in particular for the treatment of many human cancers including breast, prostat...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc.14.28

    authors: Jeong Y,Kwon D,Hong S

    更新日期:2014-05-01 00:00:00

  • Butterfly structure: a scaffold of therapeutic importance.

    abstract::Graphical abstract [Formula: see text]. ...

    journal_title:Future medicinal chemistry

    pub_type: 社论

    doi:10.4155/fmc-2019-0313

    authors: Choudhary S,Silakari O

    更新日期:2020-02-01 00:00:00

  • Recent advances in the design and synthesis of heterocycles as anti-tubercular agents.

    abstract::Due to the unusual structure and chemical composition of the mycobacterial cell wall, effective tuberculosis (TB) treatment is difficult, making many antibiotics ineffective and hindering the entry of drugs. With approximately 33% of infection, TB is still the second most deadly infectious disease worldwide. The reaso...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc.10.227

    authors: Chauhan PM,Sunduru N,Sharma M

    更新日期:2010-09-01 00:00:00

  • Nanoformulations for glioblastoma multiforme: a new hope for treatment.

    abstract::Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults, associated with a high mortality rate and a survival of between 12 and 15 months after diagnosis. Due to current treatment limitations involving surgery, radiotherapy and chemotherapy with temozolamide, there is a high rate of tr...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc-2018-0521

    authors: Ortiz R,Cabeza L,Perazzoli G,Jimenez-Lopez J,García-Pinel B,Melguizo C,Prados J

    更新日期:2019-09-01 00:00:00

  • A beginner's guide to chemokines.

    abstract::This review provides an overview of chemokines and their receptors, with an emphasis on general features and nomenclature along with a short summary of their properties and functions. It is intended as an introduction to the subject and a reference point for those wishing to learn key facts about chemokines and their ...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc.12.49

    authors: Vinader V,Afarinkia K

    更新日期:2012-05-01 00:00:00

  • Making way for suppressing the FGF19/FGFR4 axis in cancer.

    abstract::FGF19 is a noncanonical FGF ligand that can control a broad spectrum of physiological responses, which include bile acid homeostasis, liver metabolism and glucose uptake. Many of these responses are mediated by FGF19 binding to its FGFR4/β-klotho receptor complex and controlling activation of an array of intracellular...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc-2018-0099

    authors: Prieto-Dominguez N,Shull AY,Teng Y

    更新日期:2018-10-01 00:00:00

  • The dextrans as vehicles for gene and drug delivery.

    abstract::Dextran has become a hot research topic in drug vehicle material because of its biodegradable, nonspecific cell adhesion, resistance to protein adsorption, low price and ease of structural modification. The fate and changes of dextran in vivo are not fully understood. It is helpful to guide the design and modification...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc-2018-0586

    authors: Huang S,Huang G

    更新日期:2019-07-01 00:00:00

  • Microwave synthesis of cucurbit[n]urils.

    abstract:BACKGROUND:Cucurbit[n]urils (CB[n]; n = 5, 6, 7, 8 or 10) are a family of macrocycles made from the acid-catalyzed condensation of glycoluril and formaldehyde. RESULTS:The synthesis of CB[n] using microwave radiation has been examined and the effect of acid type, reaction time and temperature on the distribution of pr...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc.09.118

    authors: Wheate NJ,Patel N,Sutcliffe OB

    更新日期:2010-02-01 00:00:00

  • Computer tools in the discovery of HIV-1 integrase inhibitors.

    abstract::Computer-aided drug design (CADD) methodologies have made great advances and contributed significantly to the discovery and/or optimization of many clinically used drugs in recent years. CADD tools have likewise been applied to the discovery of inhibitors of HIV-1 integrase, a difficult and worthwhile target for the d...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc.10.193

    authors: Liao C,Nicklaus MC

    更新日期:2010-07-01 00:00:00

  • The critical role of epigallocatechin gallate in regulating mitochondrial metabolism.

    abstract::Epigallocatechin gallate (EGCG), one of polyphenols isolated from green tea, exhibits biology-benefiting effects with minimum severe adverse. EGCG is known to be a mitochondrion-targeting medicinal agent, regulating mitochondrial metabolism, including mitochondrial biogenesis, mitochondrial bioenergetics, and mitochon...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc-2017-0204

    authors: Shi W,Li L,Ding Y,Yang K,Chen Z,Fan X,Jiang S,Guan Y,Liu Z,Xu D,Wu L

    更新日期:2018-04-01 00:00:00

  • Membrane-targeting antibiotics: recent developments outside the peptide space.

    abstract::The rise of antibiotic resistant bacteria requires unconventional strategies toward efficient chemotherapeutic agents, preferably with alternative mechanisms of action. The bacterial cell membrane has become an appealing target since its essential and highly conservative structure are key challenges to resistance mech...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc-2018-0254

    authors: Dias C,Rauter AP

    更新日期:2019-02-25 00:00:00

  • Foamy matters: an update on Quillaja saponins and their use as immunoadjuvants.

    abstract::Immunoadjuvant Quillaja spp. tree saponins stimulate both cellular and humoral responses, significantly widening vaccine target pathogen spectra. Host toxicity of specific saponins, fractions and extracts may be rather low and further reduced using lipid-based delivery systems. Saponins contain a hydrophobic central a...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc-2018-0438

    authors: Magedans YV,Yendo AC,Costa F,Gosmann G,Fett-Neto AG

    更新日期:2019-06-01 00:00:00

  • Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis.

    abstract::Fingolimod (FTY720) is a first-in-class, orally active, sphingosine 1-phosphate (S1P)-receptor modulator with a structure closely related to sphingosine. The compound was discovered by chemical modification of a natural product, myriocin. Phosphorylated form of FTY720 acts as a functional antagonist at S1P receptor ty...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc.12.25

    authors: Chiba K,Adachi K

    更新日期:2012-04-01 00:00:00

  • Label-free screening assays: a strategy for finding better drug candidates.

    abstract::The last 10 years have seen advances in automation and high-throughput biochemistry in the drug-discovery arena. However, these advances have not led to improvements in drug-discovery success. Drug programs must find new ways to identify superior compounds. Advances in label-free assay technologies may provide advanta...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc.10.246

    authors: Lunn CA

    更新日期:2010-11-01 00:00:00

  • ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease.

    abstract::Alzheimer's disease (AD) is the most common cause of dementia with no cure at present. Cholesterol metabolism is closely associated with AD at several stages. ACAT1 converts free cholesterol to cholesteryl esters, and plays important roles in cellular cholesterol homeostasis. Recent studies show that in a mouse model,...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc.15.161

    authors: Shibuya Y,Chang CC,Chang TY

    更新日期:2015-01-01 00:00:00

  • Nanodelivery systems for overcoming limited transportation of therapeutic molecules through the blood-brain barrier.

    abstract::Due to the impermeable structure and barrier function of the blood-brain barrier (BBB), the delivery of therapeutic molecules into the CNS is extremely limited. Nanodelivery systems are regarded as the most effective and versatile carriers for the CNS, as they can transport cargo molecules across the BBB via various m...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc-2018-0208

    authors: Kim KT,Lee HS,Lee JJ,Park EK,Lee BS,Lee JY,Bae JS

    更新日期:2018-11-01 00:00:00

  • Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities.

    abstract::Nicotinic receptors are membrane proteins involved in several physiological processes. They are considered suitable drug targets for various CNS disorders or conditions, as shown by the large number of compounds which have entered clinical trials. In recent years, nonconventional agonists have been discovered: positiv...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc-2017-0169

    authors: Manetti D,Bellucci C,Chiaramonte N,Dei S,Teodori E,Romanelli MN

    更新日期:2018-02-01 00:00:00

  • Carbonic anhydrase activators.

    abstract::Mammalian carbonic anhydrases (CAs; EC 4.2.1.1) of which 16 isoforms are known, are involved in important physiological functions. Their inhibition is exploited pharmacologically for the treatment of many diseases (glaucoma, edema, epilepsy, obesity, hypoxic tumors, neuropathic pain, etc.) but the activators were less...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc-2017-0223

    authors: Supuran CT

    更新日期:2018-03-01 00:00:00

  • Collaboration versus outsourcing: the need to think outside the box.

    abstract::As has been widely reviewed elsewhere, the pharmaceutical industry is experiencing an 'innovation deficit' as evidenced by the decline in new chemical entity output. This decline, compounded by increased costs and regulatory requirements highlights the need to significantly revise strategic options across the drug-dis...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc.11.160

    authors: Robertson GM,Mayr LM

    更新日期:2011-12-01 00:00:00

  • Matrix metalloproteinases: new directions toward inhibition in the fight against cancers.

    abstract::Matrix metalloproteinases are zinc-dependent enzymes whose main function is to cleave the components of the extracellular matrix. Their overexpression is evident in all cancers but to date there is no satisfactory way to inhibit their actions. Here, we look at their types, their structures, their functions and the dev...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc.15.184

    authors: King SE

    更新日期:2016-01-01 00:00:00

  • Novel anthraquinone compounds as anticancer agents and their potential mechanism.

    abstract::Anthraquinones exhibit a unique anticancer activity. Since their discovery, medicinal chemists have made several structural modifications, resulting in the design and synthesis of a large number of novel anthraquinone compounds with different biological activities. In general, anthraquinone compounds have been conside...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc-2019-0322

    authors: Tian W,Wang C,Li D,Hou H

    更新日期:2020-04-01 00:00:00

  • Chromenes: potential new chemotherapeutic agents for cancer.

    abstract::Cancer is a major devastating disease, and is a leading cause of death worldwide. Despite the progress in cancer treatment, cancer mortality rate remains high. Therefore, the discovery and development of improved anticancer drugs to treat cancer are needed. 4H-chromenes have strong cytotoxicity against a panel of huma...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc.13.126

    authors: Patil SA,Patil R,Pfeffer LM,Miller DD

    更新日期:2013-09-01 00:00:00

  • Identification of agents targeting FtsZ assembly.

    abstract::Filamenting temperature-sensitive mutant Z (FtsZ), an essential cell division protein in bacteria, has recently emerged as an important and exploitable antibacterial target. Cytokinesis in bacteria is regulated by the assembly dynamics of this protein, which is ubiquitously present in eubacteria. The perturbation of F...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc-2016-0041

    authors: Panda D,Bhattacharya D,Gao QH,Oza PM,Lin HY,Hawkins B,Hibbs DE,Groundwater PW

    更新日期:2016-06-01 00:00:00

  • Advances in antibiotic drug discovery: reducing the barriers for antibiotic development.

    abstract::Antibiotic drug discovery has been an essential field of research since the early 1900s, but the threat from infectious bacteria has only increased over the decades because of the emergence of widespread multidrug resistance. In this review, we discuss the recent advances in natural product, computational and medicina...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc-2020-0247

    authors: Murphy KE,Sloan GF,Lawhern GV,Volk GE,Shumate JT,Wolfe AL

    更新日期:2020-11-01 00:00:00

  • Carbonic anhydrase IX inhibitors in cancer therapy: an update.

    abstract::Carbonic anhydrases (CAs; EC 4.2.1.1) are well known zinc metalloproteins involved in the catalysis of a very simple but essential physiological reaction: carbon dioxide hydration to bicarbonate and proton. These enzymes are of clinical relevance in cancer therapy as among the 15 isoforms known in humans, two cell sur...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.4155/fmc.15.71

    authors: Supuran CT,Winum JY

    更新日期:2015-01-01 00:00:00

  • Enhancing anticancer activity through the combination of bioreducing agents and triterpenes.

    abstract:AIM:Triterpenes are natural compounds, whose wide biological activity predestines them for application as promising new chemotherapeutics. In this paper, we report the results of our investigations into the substitution of oleanolic acid with aromatic and nitroaromatic moieties acting as bioreducing agents. RESULTS:Th...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc-2017-0154

    authors: Bednarczyk-Cwynar B,Ruszkowski P,Jarosz T,Krukiewicz K

    更新日期:2018-03-01 00:00:00

  • PAAP: a web server for predicting antihypertensive activity of peptides.

    abstract:AIM:Hypertension is associated with development of cardiovascular disease and has become a significant health problem worldwide. Naturally-derived antihypertensive peptides have emerged as promising alternatives to synthetic drugs. MATERIALS & METHODS:This study introduces predictor of antihypertensive activity of pep...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc-2017-0300

    authors: Win TS,Schaduangrat N,Prachayasittikul V,Nantasenamat C,Shoombuatong W

    更新日期:2018-08-01 00:00:00

  • Analysis of structure-based virtual screening studies and characterization of identified active compounds.

    abstract::Structure-based virtual screening makes explicit or implicit use of 3D target structure information to detect novel active compounds. Results of nearly 300 currently available original applications have been analyzed to characterize the state-of-the-art in this field. Compound selection from docking calculations is mu...

    journal_title:Future medicinal chemistry

    pub_type: 杂志文章

    doi:10.4155/fmc.12.18

    authors: Ripphausen P,Stumpfe D,Bajorath J

    更新日期:2012-04-01 00:00:00